CYTOMEGALOVIRUS DUODENITIS

CYTOMEGALOVIRUS DUODENITIS was reported 70 times

CYTOMEGALOVIRUS DUODENITIS is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor [EPC] 16 0.0007
1 CD38-directed Cytolytic Antibody [EPC] 3 0.0005
2 Antimetabolite Immunosuppressant [EPC] 4 0.0002
3 Purine Antimetabolite [EPC] 10 0.0001
4 Nucleoside Analog Antiviral [EPC] 8 0.0001
5 Human Immunoglobulin G [EPC] 1 0.0000
6 Bile Acid [EPC] 1 0.0000
7 Corticosteroid [EPC] 46 0.0000
8 Calcineurin Inhibitor Immunosuppressant [EPC] 4 0.0000
9 Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC] 3 0.0000
10 Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC] 3 0.0000
11 Polyene Antifungal [EPC] 1 0.0000
12 CD20-directed Cytolytic Antibody [EPC] 6 0.0000
13 Glycopeptide Antibacterial [EPC] 1 0.0000
14 Topoisomerase Inhibitor [EPC] 1 0.0000
15 Azole Antifungal [EPC] 2 0.0000
16 Arteriolar Vasodilator [EPC] 1 0.0000
17 Alkylating Drug [EPC] 3 0.0000
18 Dihydrofolate Reductase Inhibitor Antibacterial [EPC] 1 0.0000
19 Programmed Death Receptor-1 Blocking Antibody [EPC] 1 0.0000
20 5-alpha Reductase Inhibitor [EPC] 1 0.0000
21 Antirheumatic Agent [EPC] 1 0.0000
22 Fluoroquinolone Antibacterial [EPC] 1 0.0000
23 Folate Analog Metabolic Inhibitor [EPC] 3 0.0000
24 Thalidomide Analog [EPC] 3 0.0000
25 Opioid Agonist [EPC] 1 0.0000
26 Platinum-based Drug [EPC] 1 0.0000
27 Nucleoside Metabolic Inhibitor [EPC] 1 0.0000
28 Vitamin D [EPC] 1 0.0000
29 Angiotensin 2 Receptor Blocker [EPC] 1 0.0000
30 Vitamin B12 [EPC] 1 0.0000
31 Dihydropyridine Calcium Channel Blocker [EPC] 1 0.0000
32 HMG-CoA Reductase Inhibitor [EPC] 1 0.0000
33 Vitamin C [EPC] 1 0.0000
34 Nonsteroidal Anti-inflammatory Drug [EPC] 3 0.0000
35 Insulin Analog [EPC] 1 0.0000
36 Loop Diuretic [EPC] 1 0.0000
37 Kinase Inhibitor [EPC] 1 0.0000
38 Proton Pump Inhibitor [EPC] 1 0.0000